Insider Trades
News
prnewswire.comGalmed Announces Results from First-in-Man Pharmacokinetics Study of Oral Formulation of Aramchol Meglumine (AM); 400mg AM Increases Bioavailability by ~500% in Comparison to Aramchol Free Acid (AA) 300mgprnewswire.comMay 14
fool.com4 Dividend Energy Stocks to Buy in Mayfool.comMay 11
zacks.comAntero Midstream Q1 Earnings Miss Estimates, Revenues Increase Y/Yzacks.comMay 4
seekingalpha.comAntero Midstream: Expects High-Single Digits Adjusted EBITDA Growth In 2027 And 2028seekingalpha.comApr 30
seekingalpha.comAntero Midstream Corporation (AM) Q1 2026 Earnings Call Transcriptseekingalpha.comApr 30